Emmanuel Papadakis
Stock Analyst at Deutsche Bank
(4.03)
# 1,722
Out of 5,053 analysts
1025
Total ratings
52.7%
Success rate
4%
Average return
Main Sectors:
Stocks Rated by Emmanuel Papadakis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: NOVN Novartis AG | Reiterated: Hold | CHF 120.00 | CHF 119.30 | +0.59% | 141 | Sep 29, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Hold | CHF 340.00 | CHF 359.80 | -5.50% | 142 | Sep 29, 2026 | |
| EPA: SAN Sanofi | Reiterated: Buy | €95.00 | €70.74 | +34.29% | 148 | Sep 29, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Hold | 11,700p | 11,896p | -1.65% | 197 | Sep 29, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | 2,000p | 1,753p | +14.09% | 175 | Sep 29, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $140 | $89.01 | +57.29% | 33 | Aug 26, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Reiterated: Buy | kr 285.00 → kr 515.00 | kr 427.20 | +20.55% | 18 | Jul 21, 2026 | |
| SWX: SDZ Sandoz Group AG | Reiterated: Hold | CHF 70.00 → CHF 65.00 | CHF 71.64 | -9.27% | 9 | Apr 30, 2026 | |
| NVO Novo Nordisk | Downgraded: Hold | n/a | $38.06 | - | 16 | Feb 23, 2026 | |
| ARGX argenx SE | Downgraded: Hold | n/a | $802.64 | n/a | 2 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €11.00 → €12.00 | €9.80 | n/a | 28 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 → €14.00 | €9.83 | n/a | 12 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €22.00 | €26.24 | n/a | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $39.12 | n/a | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 1.00 | CHF 4.03 | n/a | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $85 → $80 | $216.25 | n/a | 13 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1,166.51 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $14 | $5.38 | n/a | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $7.17 | n/a | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €95.00 → €124.00 | €142.60 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $53.77 | n/a | 3 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $36.57 | n/a | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €44.00 | €52.95 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $123 → $56 | $29.05 | n/a | 2 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $46.27 | n/a | 5 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $20.78 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €80.00 | €44.15 | n/a | 31 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €62.00 → €78.00 | €137.60 | n/a | 2 | Jan 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $142.41 | n/a | 4 | Dec 7, 2018 |
Novartis AG
Sep 29, 2026
Reiterated: Hold
Price Target: CHF 120.00
Current: CHF 119.30
Upside: +0.59%
Roche Holding AG
Sep 29, 2026
Reiterated: Hold
Price Target: CHF 340.00
Current: CHF 359.80
Upside: -5.50%
Sanofi
Sep 29, 2026
Reiterated: Buy
Price Target: €95.00
Current: €70.74
Upside: +34.29%
AstraZeneca PLC
Sep 29, 2026
Reiterated: Hold
Price Target: 11,700p
Current: 11,896p
Upside: -1.65%
GSK plc
Sep 29, 2026
Reiterated: Hold
Price Target: 2,000p
Current: 1,753p
Upside: +14.09%
BioNTech SE
Aug 26, 2026
Reiterated: Buy
Price Target: $140
Current: $89.01
Upside: +57.29%
Swedish Orphan Biovitrum AB (publ)
Jul 21, 2026
Reiterated: Buy
Price Target: kr 285.00 → kr 515.00
Current: kr 427.20
Upside: +20.55%
Sandoz Group AG
Apr 30, 2026
Reiterated: Hold
Price Target: CHF 70.00 → CHF 65.00
Current: CHF 71.64
Upside: -9.27%
Novo Nordisk
Feb 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $38.06
Upside: -
argenx SE
Sep 11, 2025
Downgraded: Hold
Price Target: n/a
Current: $802.64
Upside: n/a
Aug 5, 2025
Reiterated: Hold
Price Target: €11.00 → €12.00
Current: €9.80
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: €12.00 → €14.00
Current: €9.83
Upside: n/a
Apr 28, 2025
Reiterated: Hold
Price Target: €22.00
Current: €26.24
Upside: n/a
Jan 30, 2025
Upgraded: Hold
Price Target: n/a
Current: $39.12
Upside: n/a
Nov 29, 2024
Reiterated: Hold
Price Target: CHF 1.00
Current: CHF 4.03
Upside: n/a
Aug 6, 2024
Upgraded: Hold
Price Target: $85 → $80
Current: $216.25
Upside: n/a
Jul 17, 2024
Reiterated: Hold
Price Target: n/a
Current: $1,166.51
Upside: n/a
Jul 2, 2024
Reiterated: Hold
Price Target: $8 → $14
Current: $5.38
Upside: n/a
Jun 18, 2024
Upgraded: Hold
Price Target: n/a
Current: $7.17
Upside: n/a
Aug 7, 2023
Reiterated: Hold
Price Target: €95.00 → €124.00
Current: €142.60
Upside: n/a
Jan 18, 2023
Downgraded: Sell
Price Target: n/a
Current: $53.77
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $36.57
Upside: n/a
Aug 9, 2022
Reiterated: Hold
Price Target: €44.00
Current: €52.95
Upside: n/a
Aug 6, 2021
Downgraded: Hold
Price Target: $123 → $56
Current: $29.05
Upside: n/a
Apr 16, 2021
Reiterated: Sell
Price Target: n/a
Current: $46.27
Upside: n/a
Jul 15, 2020
Reiterated: Hold
Price Target: n/a
Current: $20.78
Upside: n/a
Jul 14, 2020
Reiterated: Buy
Price Target: €80.00
Current: €44.15
Upside: n/a
Jan 15, 2019
Reiterated: Sell
Price Target: €62.00 → €78.00
Current: €137.60
Upside: n/a
Dec 7, 2018
Downgraded: Sell
Price Target: n/a
Current: $142.41
Upside: n/a